SHANGHAI HONGENE BIOTECH CORP

Overview

SHANGHAI HONGENE BIOTECH CORP is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering LIGATION ENZYME.

API / Drug Master Files

SHANGHAI HONGENE BIOTECH CORP holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LIGATION ENZYMEActive2024-06-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANGHAI HONGENE BIOTECH CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.